Bryce Point Capital LLC Acquires New Holdings in Genpact Limited (NYSE:G)

Bryce Point Capital LLC bought a new position in shares of Genpact Limited (NYSE:GFree Report) during the 4th quarter, Holdings Channel reports. The institutional investor bought 11,356 shares of the business services provider’s stock, valued at approximately $488,000.

Other institutional investors have also recently bought and sold shares of the company. SRH Advisors LLC bought a new stake in shares of Genpact in the fourth quarter worth $26,000. Manchester Capital Management LLC acquired a new position in shares of Genpact during the 4th quarter worth about $38,000. Smartleaf Asset Management LLC grew its holdings in shares of Genpact by 416.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock valued at $41,000 after acquiring an additional 783 shares in the last quarter. UMB Bank n.a. increased its position in shares of Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after acquiring an additional 433 shares during the last quarter. Finally, J.Safra Asset Management Corp boosted its position in Genpact by 38.8% during the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider’s stock valued at $69,000 after purchasing an additional 453 shares during the last quarter. Institutional investors own 96.03% of the company’s stock.

Insiders Place Their Bets

In related news, SVP Piyush Mehta sold 12,000 shares of the business’s stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares of the company’s stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the company’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares of the company’s stock, valued at $15,167,926.94. This represents a 4.20 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Needham & Company LLC boosted their price target on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Mizuho upped their price target on shares of Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Jefferies Financial Group raised shares of Genpact from a “hold” rating to a “buy” rating and lifted their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, TD Cowen upgraded Genpact from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Six research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $48.44.

Check Out Our Latest Report on G

Genpact Price Performance

Genpact stock opened at $47.08 on Friday. The company has a market capitalization of $8.27 billion, a price-to-earnings ratio of 16.58, a PEG ratio of 1.84 and a beta of 1.06. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The stock’s 50 day moving average is $51.20 and its 200-day moving average is $45.39.

Genpact (NYSE:GGet Free Report) last issued its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Equities research analysts expect that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were issued a $0.17 dividend. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.44%. This is an increase from Genpact’s previous quarterly dividend of $0.15. Genpact’s payout ratio is currently 23.94%.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.